SCHEMBL6544086

SCHEMBL6544086

COC(=O)c1ccc(N(C)C(C(=O)Cc2ccc(NC(=O)Nc3ccccc3F)c(OC)c2)C2CCCN2)c(N)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PYGL P06737 1/20 0.40
▸ KDM4E B2RXH2 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ RAB9A P51151 3/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ LNPEP Q9UIQ6 3/20 0.36
▸ ERAP2 Q6P179 2/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ MEN1 O00255 4/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ ITGA4 P13612 2/20 0.35
▸ ITGB1 P05556 1/20 0.35
▸ CHEK1 O14757 1/20 0.35
▸ CASP3 P42574 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5149792 0.90 MEN1 (0.41) PYGLKDM4EMAPTRAB9ANPC1
SCHEMBL6543574 0.85 ALDH1A1 (0.41) PYGLKDM4ERAB9ANPC1PDE4D
SCHEMBL5152038 0.84 MEN1 (0.41) PYGLMAPTRAB9ASMN1; SMN2PDE4D
SCHEMBL5151912 0.81 ITGA4 (0.46) MAPTRAB9ANPC1SMN1; SMN2MEN1
SCHEMBL5157221 0.77 ITGA4 (0.48) SMN1; SMN2ITGA4ITGB1CHEK1
SCHEMBL5152912 0.76 ITGA4 (0.51) PYGLKDM4EMAPTRAB9ANPC1
SCHEMBL6207924 0.74 ITGA4 (0.37) MAPTRAB9ALNPEPERAP2MEN1
SCHEMBL5153126 0.73 ITGA4 (0.48) MAPTRAB9ANPC1SMN1; SMN2MEN1
SCHEMBL5156521 0.72 ITGA4 (0.45) PYGLSMN1; SMN2MEN1KMT2AITGA4
SCHEMBL5151749 0.72 ITGA4 (0.43) MAPTMEN1KMT2AITGA4ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6756378-B2 BENZYL -UREA, -THIOUREA, OR -GUANIDINE DERIVATIVES THAT INHIBIT THE BINDING OF LIGANDS TO ALPHA 4 BETA 1 INTEGRIN (VLA-4) PHARMACOPEIA DRUG DISCOVERY, INC. 2004-06-29 — — US disclosed
Send feedback